Synthesis and Structure−Activity Relationships of 3,8-Diazabicyclo[4.2.0]octane Ligands, Potent Nicotinic Acetylcholine Receptor Agonists-Reference-Cited by-同舟云学术

Synthesis and Structure−Activity Relationships of 3,8-Diazabicyclo[4.2.0]octane Ligands, Potent Nicotinic Acetylcholine Receptor Agonists

Published:2006-12-01 Issue:26 Volume:49 Page:7843-7853
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Frost (née Pac Jennifer M.¹,Bunnelle William H.¹,Tietje Karin R.¹,Anderson David J.¹,Rueter Lynne E.¹,Curzon Peter¹,Surowy Carol S.¹,Ji Jianquo¹,Daanen Jerome F.¹,Kohlhaas Kathy L.¹,Buckley Michael J.¹,Henry Rodger F.¹,Dyhring Tino¹,Ahring Philip K.¹,Meyer Michael D.¹

Affiliation:

1. Neuroscience Research, Abbott Laboratories, Abbott Park, Illinois 60064, and NeuroSearch A/S, 93 Pederstrupvej, DK-2750 Ballerup, Denmark

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm060846z

Reference37 articles.

1. Nicotinic acetylcholine receptors in health and disease

2. Neuronal nicotinic receptors in the human brain

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CPA-catalyzed multicomponent reaction of anilines, aldehydes, and azetidinones: Rapid access to enantiopure-fused azetidines;Chem Catalysis;2022-08

2. Applications of Isosteres of Piperazine in the Design of Biologically Active Compounds: Part 1;Journal of Agricultural and Food Chemistry;2022-06-08

3. Stereoselective Bulk Synthesis of CCR2 Antagonist BMS-741672: Assembly of an All-cis (S,R,R)-1,2,4-Triaminocyclohexane (TACH) Core via Sequential Heterogeneous Asymmetric Hydrogenations;Organic Process Research & Development;2016-10-25

4. Discovery of Highly Potent Dual Orexin Receptor Antagonists via a Scaffold-Hopping Approach;ChemMedChem;2016-07-08

5. Engineered α4β2 nicotinic acetylcholine receptors as models for measuring agonist binding and effect at the orthosteric low-affinity α4–α4 interface;Neuropharmacology;2015-05